Adaptive immunity of type VI CRISPR-Cas systems associated with reverse transcriptase–Cas1 fusion proteins
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae1154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von María Dolores Molina-Sánchez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Soil and Plant Microbiology, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Structure, Dynamics and…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA-Directed DNA Polymerase, CRISPR-Associated Proteins, Adaptive Immunity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Consejeria de Transformacion Economica, industria, Conocimiento y Universidades, ERDF A way of making Europe.
Abstract (Originalsprache)
Cas13-containing type VI CRISPR-Cas systems specifically target RNA; however, the mechanism of spacer acquisition remains unclear. We have previously reported the association of reverse transcriptase–Cas1 (RT–Cas1) fusion proteins with certain types of VI-A systems. Here, we show that RT–Cas1 fusion proteins are also recruited by type VI-B systems in bacteria from gut microbiomes, constituting a VI-B1 variant system that includes a CorA-encoding locus in addition to the CRISPR array and the RT–Cas1/Cas2 adaptation module. We found that type VI RT-CRISPR systems were functional for spacer acquisition, CRISPR array processing and interference activity, demonstrating that adaptive immunity mediated by these systems can function independently of other in trans systems. We provide evidence that the RT associated with these systems enables spacer acquisition from RNA molecules. We also found that CorA encoded by type VI-B1 RT-associated systems can transport divalent metal ions and downregulate Cas13b-mediated RNA interference. These findings highlight the importance of RTs in RNA-targeting CRISPR-Cas systems, potentially enabling the integration of RNA-derived spacers into CRISPR arrays as a mechanism against RNA-based invaders in specific environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Soil and Plant Microbiology, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Structure, Dynamics and Function of Bacterial Genomes, Grupo de Ecología Genética de la Rizos…
- Section of Microbiology, Department of Biology, University of Copenhagen, Universitetsparken 15, 2100 Copenhagen, Denmark.
- Groningen Biomolecular & Biotechnology Institute, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands.
ORCID-Profile: María Dolores Molina-Sánchez, Francisco Martínez-Abarca, Albert Guskov, Nicolás Toro
Förderung
- Consejeria de Transformacion Economica, industria, Conocimiento y Universidades
- ERDF A way of making Europe
Zitieren
APA
Molina-Sánchez, M. D., Martínez-Abarca, F., Millán, V., Mestre, M. R., Stehantsev, P., Stetsenko, A., Guskov, A., & Toro, N. (2024). Adaptive immunity of type VI CRISPR-Cas systems associated with reverse transcriptase–Cas1 fusion proteins. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae1154
Vancouver
Molina-Sánchez MD, Martínez-Abarca F, Millán V, Mestre MR, Stehantsev P, Stetsenko A, et al. Adaptive immunity of type VI CRISPR-Cas systems associated with reverse transcriptase–Cas1 fusion proteins. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae1154
BibTeX
@article{MolinaSnchez2024,
author = {Molina-Sánchez, María Dolores and Martínez-Abarca, Francisco and Millán, Vicenta and Mestre, Mario Rodríguez and Stehantsev, Pavlo and Stetsenko, Artem and Guskov, Albert and Toro, Nicolás},
title = {Adaptive immunity of type VI CRISPR-Cas systems associated with reverse transcriptase–Cas1 fusion proteins},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae1154}
}
EUVIMED